%D9%81%D9%8A%D8%B1%D9%88%D8%B3_%D9%85%D8%AD%D9%84%D9%84_%D9%84%D9%84%D9%88%D8%B1%D9%85Onkolytische_VirenOncolytic_virusVirus_oncol%C3%ADtico%D9%88%DB%8C%D8%B1%D9%88%D8%B3_%D8%A2%D9%86%DA%A9%D9%88%D9%84%DB%8C%D8%AA%DB%8C%DA%A9Onkolyyttinen_virushoitoVirus_onkolisisVirus_oncolitici%E8%85%AB%E7%98%8D%E6%BA%B6%E8%A7%A3%E6%80%A7%E3%82%A6%E3%82%A4%E3%83%AB%E3%82%B9Wirus_onkolitycznyQ1560099
about
sameAs
Exploiting tumor epigenetics to improve oncolytic virotherapyImaging characteristics, tissue distribution, and spread of a novel oncolytic vaccinia virus carrying the human sodium iodide symporterSystemic therapy for cervical cancer with potentially regulatable oncolytic adenovirusesInsertion of the human sodium iodide symporter to facilitate deep tissue imaging does not alter oncolytic or replication capability of a novel vaccinia virusSynergistic antitumor activity of oncolytic reovirus and chemotherapeutic agents in non-small cell lung cancer cellsOncolytic viruses as therapeutic cancer vaccinesSystemic delivery of oncolytic viruses: hopes and hurdlesCombination of a novel oncolytic immunotherapeutic agent, CAVATAK (coxsackievirus A21) and immune-checkpoint blockade significantly reduces tumor growth and improves survival in an immune competent mouse melanoma modelImmune recruitment and therapeutic synergy: keys to optimizing oncolytic viral therapy?Thunder and lightning: immunotherapy and oncolytic viruses collideOncolytic specificity of Newcastle disease virus is mediated by selectivity for apoptosis-resistant cellsOncolytic measles viruses encoding interferon beta and the thyroidal sodium iodide symporter gene for mesothelioma virotherapyImproved systemic delivery of oncolytic reovirus to established tumors using preconditioning with cyclophosphamide-mediated Treg modulation and interleukin-2Cancer cell death enhances the penetration and efficacy of oncolytic herpes simplex virus in tumorsCell carriage, delivery, and selective replication of an oncolytic virus in tumor in patientsVEGF blockade enables oncolytic cancer virotherapy in part by modulating intratumoral myeloid cellsEngineered newcastle disease virus as an improved oncolytic agent against hepatocellular carcinomaIntelligent design: combination therapy with oncolytic virusesPotentiating cancer immunotherapy using an oncolytic virusEnhancement of oncolytic properties of recombinant newcastle disease virus through antagonism of cellular innate immune responsesPhase I/II study of oncolytic herpes simplex virus NV1020 in patients with extensively pretreated refractory colorectal cancer metastatic to the liverPreclinical pharmacology and toxicology of intravenous MV-NIS, an oncolytic measles virus administered with or without cyclophosphamideAnti-VEGF single-chain antibody GLAF-1 encoded by oncolytic vaccinia virus significantly enhances antitumor therapyONCOLYTIC EFFECT OF POLIOMYELITIS VIRUS ON HUMAN EPIDERMOID CARCINOMA (HELA TUMOR) HETEROLOGOUSLY TRANSPLANTED TO GUINEA PIGSHeat shock protein 72 expression allows permissive replication of oncolytic adenovirus dl1520 (ONYX-015) in rat glioblastoma cellsMathematical modeling of tumor therapy with oncolytic viruses: regimes with complete tumor elimination within the framework of deterministic models.Oncolytic virus therapy: A new era of cancer treatment at dawnOncolytic Viruses: Therapeutics With an Identity CrisisOncolytic viruses as immunotherapy: progress and remaining challengesClinical development of reovirus for cancer therapy: An oncolytic virus with immune-mediated antitumor activityMoving oncolytic viruses into the clinic: clinical-grade production, purification, and characterization of diverse oncolytic virusesVaccine Therapy, Oncolytic Viruses, and GliomasRetargeting Strategies for Oncolytic Herpes Simplex VirusesCRISPR-Cas9 as a Powerful Tool for Efficient Creation of Oncolytic VirusesBig Data Offers Novel Insights for Oncolytic Virus ImmunotherapyTo Infection and Beyond: The Multi-Pronged Anti-Cancer Mechanisms of Oncolytic VirusesOvercoming Barriers in Oncolytic Virotherapy with HDAC Inhibitors and Immune Checkpoint BlockadeExploring Reovirus Plasticity for Improving Its Use as Oncolytic VirusOncolytic viruses: finally deliveringDendritic Cells in Oncolytic Virus-Based Anti-Cancer Therapy
P921
Q21131237-1665F24C-27D6-4967-9947-2A716EED7357Q21134124-638E0FC4-66A1-4197-8254-EF9E08444287Q21144267-607624AA-832E-4EAC-BB9A-D55A0FA1D51FQ21245462-AFF9AF04-C9A0-477D-ACC1-62F8D55840A6Q21245717-3F9EEA70-E8CA-4E9A-9B3B-A8EAD4DB281EQ21245758-B04F5E48-6846-40D4-9555-D4B119BC7F08Q21284969-E75A173F-FCFC-4B2B-9C23-6CD0FDA736D1Q22001064-8E21E68A-E785-4026-903A-7CA710E196C1Q24596171-CF5FCC7C-AF3E-48D7-BC28-02E61468A9C2Q24597894-C341B783-A3E8-4D19-9375-A5436AB5BC25Q24602706-71303FEC-655C-4049-863B-E9180BE6B56EQ24605512-F8D38CE7-219E-4D4F-BE82-E03BB1027A0BQ24612603-ED5AC93A-A417-4299-A7EF-7BD54B28C5E4Q24614856-D793D771-A03D-4EDD-849A-972ED7AE1D86Q24617027-22DA928F-C9CE-46F2-9954-CBCDB79E0051Q24618562-F57EC332-B2A8-4F01-946A-2E4772BE7095Q24628144-2B4CDE34-B10F-4BDE-837A-EBFC9FB785CCQ24628227-A9854E36-820F-4E47-96FB-D50CD595FDADQ24628810-37676FDB-BC58-4F1C-895C-70F71DD03EF4Q24631361-A1D2053C-D4D6-4E2F-A9AC-691E7EC44E90Q24633957-EACD67E9-E16B-41DF-B7A1-3585117701D8Q24647228-EDAC72D8-24E6-4AB2-93E8-8F4C33FC986BQ24655930-7651CC54-4525-4723-A2F6-C8E928025836Q24680538-97FF07D1-5BDA-4D93-946F-96AF891E06CEQ24805926-1F62CC60-06A9-4D43-B57B-526D40E7BE81Q25257260-2DBEE30E-8771-453A-B744-079AEDBF112BQ26739714-E6D433AA-FC29-46EC-8242-C422F82CAAC2Q26741020-2E98D2DE-C4F1-4B30-A9A8-D4B91159239EQ26745942-76F3E101-F206-4743-ACB2-A62269A7104FQ26750568-BBF27986-863B-4CC8-A561-0F0900692D83Q26752807-DF0E99B6-B4CB-45E5-9EA2-ED1A22849AD4Q26764981-59DBCA6D-B6C5-4540-B748-00F356E79D6DQ26765439-A7792B36-570A-4C03-AB0D-4AA317C0E44DQ26766798-628A22E2-455F-4491-8F61-199EF9461390Q26767209-FA4C2A22-84D6-498E-A25A-1EC1D4053FFDQ26767212-74A83D59-1FC3-46C9-8FF7-2074B33B904BQ26769977-E28CCF9B-2B52-4C3F-A745-35857EDAFAA8Q26771799-EC40EC0E-D1E9-4FC6-A13F-3442903E339EQ26772039-8F0A9EEE-BE77-4378-BF1C-F1E5F48EF6EAQ26774345-825CF87A-FB28-4270-99ED-EA76C5630A85
P921
name
Onkolytische Viren
@de
Onkolyyttinen virushoito
@fi
Virus oncolitici
@it
Virus oncolíticos
@es
Virus onkolisis
@id
Wirus onkolityczny
@pl
oncolytic virus
@en
onkolytisk virus
@da
onkolytisk virus
@nn
virus oncolytique
@fr
type
label
Onkolytische Viren
@de
Onkolyyttinen virushoito
@fi
Virus oncolitici
@it
Virus oncolíticos
@es
Virus onkolisis
@id
Wirus onkolityczny
@pl
oncolytic virus
@en
onkolytisk virus
@da
onkolytisk virus
@nn
virus oncolytique
@fr
altLabel
Onkolyse
@de
Onkolyyttinen virus
@fi
Onkolyyttiset virushoidot
@fi
Virus oncoliticos
@es
cancer-killing virus
@en
cancer-killing viruses
@en
prefLabel
Onkolytische Viren
@de
Onkolyyttinen virushoito
@fi
Virus oncolitici
@it
Virus oncolíticos
@es
Virus onkolisis
@id
Wirus onkolityczny
@pl
oncolytic virus
@en
onkolytisk virus
@da
onkolytisk virus
@nn
virus oncolytique
@fr
P486
P6366
P646
P279
P3827
oncolytic-viruses